6:12 am Valeant Pharma beats by $0.09, reports revs in-line; reaffirms FY14 EPS guidance, guides FY14 revs in-line
View todays social media effects on VRX
View the latest stocks trending across Twitter. Click to view dashboard
View todays social media effects on VRX
View the latest stocks trending across Twitter. Click to view dashboard